Breeze Holdings Acquisition Corp.
Status: Closed Deal
U=S+W+R
W=S@11.5
R=S/20
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Nov 23, 2020 |
| CEO | J. Douglas Ramsey, Ph.D. |
| Left Lead | I-Bankers Securities |
| IPO Cash in Trust | 101.5% |
| SPAC Tenor | 12 + 3 + 3 + 4 + 6 + 6 + 9 + 6 + 6 + 3 |
| IPO Sector | Energy ▶ |
| IPO Geography | US/Canada |
| Target Company | YD Biopharma |
| Deal Announced | Nov 1, 2022 |
| Deal Size, $M | $694.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Aug 14, 2025 |
| Amendment Vote | Jun 26, 2025 |
| Closing Date | Aug 28, 2025 |
Formerly BRZH
YDES
YDESW
| Price | $17.45 |
|---|---|
| Last closing price | $17.10 |
| H/L, today | $16.56 / $19.74 |
| Volume, today | 114,635 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.